Yanxia Guo

Yanxia Guo is an Associate Director of Immunology at GSK, specializing in novel therapeutic platform development since July 2020. Previously, Yanxia Guo served as a Senior Research Investigator in Immuno-Oncology at Bristol-Myers Squibb, where significant contributions included leading a team to develop a key biology data package that elevated a target validation program to a high-priority discovery initiative. At The Janssen Pharmaceutical Companies of Johnson & Johnson, recognition came through the Janssen Innovation Leadership Award for advancing clinical biomarker strategies in lupus. Earlier experience includes a Postdoctoral Research Fellowship at Merck, focusing on the molecular mechanisms of small molecule antagonists. Yanxia Guo holds a PhD in Immunology from Dartmouth College, obtained in 2013.